spironolactone has been researched along with Enteropathy, Exudative in 4 studies
Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We report successful diuretics treatment with spironolactone and furosemide at standard dose, of refractory PLE in a patient with Noonan syndrome and repaired congenital heart disease." | 3.81 | Successful diuretics treatment of protein-losing enteropathy in Noonan syndrome. ( Iemura, M; Kudo, Y; Matsuishi, T; Mizuochi, T; Seki, Y; Suda, K; Tanikawa, K; Yanagi, T; Yoshimoto, H, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mizuochi, T | 1 |
| Suda, K | 1 |
| Seki, Y | 1 |
| Yanagi, T | 1 |
| Yoshimoto, H | 1 |
| Kudo, Y | 1 |
| Iemura, M | 1 |
| Tanikawa, K | 1 |
| Matsuishi, T | 1 |
| Okano, S | 1 |
| Sugimoto, M | 1 |
| Takase, M | 1 |
| Iseki, K | 1 |
| Kajihama, A | 1 |
| Azuma, H | 1 |
| Ringel, RE | 1 |
| Peddy, SB | 1 |
| Ledingham, JG | 1 |
| Bayliss, RI | 1 |
4 other studies available for spironolactone and Enteropathy, Exudative
| Article | Year |
|---|---|
Successful diuretics treatment of protein-losing enteropathy in Noonan syndrome.
Topics: Child; Diuretics; Female; Fontan Procedure; Furosemide; Heart Defects, Congenital; Humans; Noonan Sy | 2015 |
Effectiveness of High-dose Spironolactone Therapy in a Patient with Recurrent Protein-losing Enteropathy after the Fontan Procedure.
Topics: Anti-Inflammatory Agents; Child; Diuretics; Fontan Procedure; Humans; Japan; Male; Protein-Losing En | 2016 |
Effect of high-dose spironolactone on protein-losing enteropathy in patients with Fontan palliation of complex congenital heart disease.
Topics: Child; Fontan Procedure; Heart Defects, Congenital; Humans; Infant; Mineralocorticoid Receptor Antag | 2003 |
Ethacrynic acid: two years' experience with a new diuretic.
Topics: Benzothiadiazines; Blood; Edema; Ethacrynic Acid; Heart Failure; Liver Cirrhosis; Nephrotic Syndrome | 1965 |